September 23rd 2023
Catch up on the top radiology news of the past week.
September 22nd 2023
September 21st 2023
September 22nd 2023
September 7th 2023
The use of automated detection of large vessel occlusion on computed tomography (CT) through artificial intelligence (AI) software reportedly led to an 11.2-minute reduction in triage time from the completion of imaging to initiation of endovascular therapy, according to newly published research.
Twice-a-day consumption of reconstituted grape powder provides significant long-term benefit in preserving cerebral metabolism for people with mild cognitive decline, according to research presented at the recent Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
Over 80 percent of head and neck computed tomography angiography (CTA) exams performed in the emergency department had no actionable findings for patients with non-focal neurologic complaints, and 67 percent of the exams were ordered by non-physician practitioners (NPPs), according to a newly published study.
In a recent interview, Sophia Rose O’Brien, M.D., shared her insights on the roles and limitations of FDG PET/CT and FES PET/CT in the imaging of patients with metastatic breast cancer.
In a recent video interview, Vivek Bansal, M.D., discussed a recent Radiology Partners publication that offers practical tips and best practice guidance on CT and MRI neuroimaging for stroke patients.
For men with PSA scores between 4 to 10 ng/mL, a multivariate prediction model that incorporates 68Ga-PSMA PET/CT had a 92.7 AUC for predicting clinically significant prostate cancer, according to newly published research.
Indicated for the triage and notification of obstructive hydrocephalus on non-contrast brain computed tomography (CT), the artificial intelligence (AI)-enabled software is reportedly the first radiology triage modality to obtain the Food and Drug Administration’s (FDA) Breakthrough Device Designation.
Abnormal findings on coronary computed tomography angiography-derived fractional flow reserve (CCTA-FFR) are associated with 3.2-fold higher risks of all-cause death or spontaneous myocardial infarction (MI) in patients with new-onset stable angina pectoris and coronary stenosis, according to newly published research.